Pulmonary Hypertension News

April 12, 2021April 12, 2021

Uptravi Can Help PAH Patients at Greatest Risk of Death, Registry Data Show

Pulmonary Hypertension News

More than three-quarters (76%) of adults with pulmonary arterial hypertension (PAH) being treated with Uptravi (selexipag) either saw no increase or a decline in their risk of death over one ... Read more

April 9, 2021April 9, 2021

Outcomes Poorer for PH-COPD Than Idiopathic PAH, Registry Data Show

Pulmonary Hypertension News

Patients whose pulmonary hypertension is associated with chronic obstructive pulmonary disease (PH-COPD) have a worse clinical status and a poorer outcome than those with idiopathic pulmonary arterial hypertension (IPAH), a study ... Read more

April 7, 2021April 7, 2021

Phase 2 Trial Updates on Sotatercept in Treating PAH Set for ATS 2021

Pulmonary Hypertension News

Treatment with Acceleron Pharma’s sotatercept appears to be effective and generally well tolerated in people with pulmonary arterial hypertension (PAH), according to new data from the ongoing PULSAR and SPECTRA ... Read more

April 5, 2021April 5, 2021

Antiparasitic Shows Potential as PAH Treatment in Preclinical Study

Pulmonary Hypertension News

Diminazene aceturate (DIZE), an approved antiparasitic medication, lessened the development of pulmonary arterial hypertension (PAH) in a rat model, a study has demonstrated. These findings support further investigation of DIZE ... Read more

April 2, 2021April 2, 2021

Low-carb, High-fat Diet Seen to Safely Treat PH With Metabolic Syndrome

Pulmonary Hypertension News

A ketogenic diet — one that’s low in carbohydrates and higher in fat  — given under medical supervision seems to be safe and effective in treating pulmonary hypertension (PH) when ... Read more

April 1, 2021April 1, 2021

Tyvaso Becomes 1st PH-ILD Treatment Approved in US

COVID-19 News, Pulmonary Hypertension News

Tyvaso (inhaled treprostinil) has become the first treatment approved in the U.S. for people with pulmonary hypertension associated with interstitial lung disease (PH-ILD). The U.S. Food and Drug Administration (FDA) ... Read more

March 31, 2021March 31, 2021

Some PAH Patients May Benefit from Switch to Adempas

Pulmonary Hypertension News

Intermediate-risk pulmonary arterial hypertension (PAH) patients may see their symptoms improve after switching from phosphodiesterase-5 inhibitors (PDE-5i) to Adempas (riociguat), results from the Phase 4 REPLACE clinical trial show. The transition ... Read more

March 30, 2021March 30, 2021

Cost of Rare Diseases in US? Nearly $1 Trillion in 2019, EveryLife Foundation Finds

Pulmonary Hypertension News

As anyone affected by a rare disease knows, treating the illness while trying to go about everyday life is an expensive undertaking.  But exactly how expensive — in terms of ... Read more

March 29, 2021March 29, 2021

Study Pinpoints Altered Biological Pathways in Endothelial Cells

Pulmonary Hypertension News

Several proteins involved in vascular remodeling, metabolism, and oxidative stress are not properly regulated in endothelial cells from patients with chronic thromboembolic pulmonary hypertension (CTEPH), a study found. The study, ... Read more

March 26, 2021March 26, 2021

PHA Publishes Guide on Risk Factors, Treatments in Newborn PH

Pulmonary Hypertension News

The Pulmonary Hypertension Association (PHA) has published a guide to educate healthcare providers and parents on persistent pulmonary hypertension of the newborn (PPHN). The goal, the PHA said, is to ... Read more

March 24, 2021March 24, 2021

PulmoSIM Therapeutics Opens With Focus on Better Treating PAH

Pulmonary Hypertension News

VeriSIM Life has opened PulmoSIM Therapeutics, its pharmaceutical subsidiary focused on developing treatments for pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF), before moving to other rare respiratory diseases. “We ... Read more

March 22, 2021March 22, 2021

Live Expert Panel to Discuss COVID-19’s Effect on Respiratory Diseases

COVID-19 News, Pulmonary Hypertension News

Experts will discuss how the COVID-19 pandemic has affected people living with pulmonary hypertension and other rare respiratory diseases during a live panel discussion this week. The event, taking place ... Read more

March 19, 2021March 19, 2021

Severe COVID-19 Infection Can Lead to Acute PH, Raising Risk of Death

COVID-19 News, Pulmonary Hypertension News

Acute pulmonary hypertension (aPH) is frequent and linked with a higher risk of mortality in people who are severely ill with COVID-19, according to a Swedish study. The study, “Acute pulmonary ... Read more

March 17, 2021March 17, 2021

Menopause at Young Ages Linked to Higher PH Risk in UK Study

Pulmonary Hypertension News

Women who reach menopause prematurely — meaning before age 40 — are two times more likely to develop pulmonary hypertension (PH) than those who do not, a study found. Analysis of medical ... Read more

March 15, 2021March 15, 2021

Pregnancy, With Care Team, Possible if PH Moderate, Study Suggests

Pulmonary Hypertension News

Although pregnancy should be avoided by women with severe pulmonary hypertension (PH), close monitoring by a multidisciplinary team may make it possible in those with moderate PH, a study from ... Read more